Anticoagulant antagonist and hemophilia procoagulant

James H Morrissey; Stephanie A Smith

Anticoagulant antagonist and hemophilia procoagulant

James H Morrissey (Inventor), Stephanie A Smith (Inventor)

Research output: Patent

Abstract

A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.

Original language	English (US)
U.S. patent number	9241958
Filing date	1/30/14
State	Published - Jan 26 2016

Library availability

Discover UIUC Full Text

Cite this

@misc{e3276b3b6acd4213812ee39e75c0f998,

title = "Anticoagulant antagonist and hemophilia procoagulant",

abstract = "A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.",

author = "Morrissey, {James H} and Smith, {Stephanie A}",

note = "FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT This application was funded in part under the following research grants and contracts: NIH (NHLBI) Grant No. R01 HL47014. The U.S. Government may have rights in this invention.; 9241958",

year = "2016",

month = jan,

day = "26",

language = "English (US)",

type = "Patent",

}

TY - PAT

T1 - Anticoagulant antagonist and hemophilia procoagulant

AU - Morrissey, James H

AU - Smith, Stephanie A

N1 - FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT This application was funded in part under the following research grants and contracts: NIH (NHLBI) Grant No. R01 HL47014. The U.S. Government may have rights in this invention.

PY - 2016/1/26

Y1 - 2016/1/26

N2 - A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.

AB - A method for treating a coagulation deficient patient comprises administering an amount of polyP to the patient sufficient to reduce the PT Test value or Dilute PT Test value of the plasma of the patient.

M3 - Patent

M1 - 9241958

Y2 - 2014/01/30

ER -

Anticoagulant antagonist and hemophilia procoagulant

Abstract

Library availability

Fingerprint

Cite this